Target intelligence / Profile preview

Serotonin secretion mechanism in enterochromaffin cell of gastrointestinal tract

Molecular classification
Other (biological process), Enzyme (Tryptophan hydroxylase 1, TPH1), Transporter (Vesicular monoamine transporter, VMAT1), Ion channel (TRPA1)
01

Overview

Serotonin secretion by enterochromaffin cells is a key process in gut physiology. EC cells, the most numerous enteroendocrine cells in the GI tract, synthesize serotonin from tryptophan via tryptophan hydroxylase 1 (TPH1), store it in vesicles via VMAT1, and release it in response to luminal stimuli such as nutrients, microbial metabolites (e.g., indoles), and mechanical forces. Released serotonin acts locally, activating sensory and motor neurons (primarily via 5-HT3 and 5-HT4 receptors), modulating motility, secretion, and communicating satiety signals to the brain. Dysregulation of EC cell serotonin secretion is implicated in numerous GI and metabolic diseases, as well as chemotherapy-induced nausea and vomiting; thus, several molecular actors involved in this process form therapeutic targets.

Other names
Serotonin release in EC cells5-HT secretion by enterochromaffin cellsgut-derived serotonin release
02

Mechanism of action

Antagonism/inhibition of 5-HT3 receptors (reduces nausea/vomiting) Modulation of serotonin synthesis/release (e.g., by targeting TPH1 or TRPA1) Alteration of serotonin reuptake or degradation Modulation of enterochromaffin cell activity via microbial metabolites or nutrients

03

Biological functions

Signal transductionGastrointestinal motilityEpithelial secretionRegulation of enteric nervous systemSatiety signalingNeurotransmission
04

Disease associations

Gastrointestinal disorders (irritable bowel syndrome, constipation, diarrhea)Gut-brain axis dysregulationMetabolic disordersNausea and vomiting (especially chemotherapy-induced)
05

Safety considerations

Serotonin syndrome from systemic excessGastrointestinal motility disturbancesNausea, vomitingDrug-drug interactions affecting serotonin pathwaysOff-target effects on CNS serotonin
06

Interacting drugs

5-HT3 receptor antagonists (e.g., ondansetron)

4 more in the full profile.

07

Biomarkers

Serotonin (5-HT) levels in plasma or stoolTPH1 mRNA or protein expression in tissueTRPA1 expression in EC cells

Beyond the preview

Go deeper on Serotonin secretion mechanism in enterochromaffin cell of gastrointestinal tract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serotonin secretion mechanism in enterochromaffin cell of gastrointestinal tract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call